EFA generates evidence, shares knowledge, launches campaigns and raises awareness of allergy and airway diseases. We bring to attention EFA’s influence and activities through our various platforms that reach out to patients, healthcare professionals and policymakers.

In 2022, we continued advancing on EFA’s long-lasting project, the Capacity Building Programme, and two partnership projects, the MEP Interest Group on Allergy and Asthma and the BREATHE Coalition, where we facilitate European-level respiratory organisations exchange and joint advocacy.